Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DECODE GENETICS-*DCGN -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (156)	11/23/2004 10:39:58 PM
From: Biotech Jim	Read Replies (1) \| Respond to of 313

DCGN is a strong buy in here, as this joint venture is further validation by Roche in their confidence in the quality of the deCODE discovery effort. I have been initiating a new position in the low 3's. As more clinical studies are published on their patients and the genetic database, more people will see the value of this technology. I'm very curious about the obesity data sets. BJ